Implementing Clinical governance in Iranian hospitals: purpose, process and pitfalls.
Journal Title: Electronic Physician - Year 2016, Vol 8, Issue 1
Abstract
Clinical governance as an approach to improving the quality and safety of clinical care has been run in all Iranian hospitals since 2009. This study aimed to provide a comprehensive overview of the processes and challenges faced in implementing clinical governance (CG) in acute-care hospitals in Iran.
Authors and Affiliations
Bahram Mohaghegh, Hamid Ravaghi, Russell Mannion, Peigham Heidarpoor, Haniye Sadat Sajadi
Immunosuppressive therapy in children with steroid-resistant, frequently-relapsing, and steroid-dependent idiopathic nephrotic syndrome: a single center experience.
Immunosuppressive agents are recommended for the management of children with steroid-resistant, frequently-relapsing, and steroid-dependent idiopathic nephrotic syndrome, i.e., SRNS, FRNS, and SDNS. This study evaluated...
Comparative effectiveness of intra-articular prolotherapy versus peri-articular prolotherapy on pain reduction and improving function in patients with knee osteoarthritis: A randomized clinical trial
BACKGROUND: Osteoarthritis is a common degenerative disease. Prolotherapy is an alternative therapy used in multiple musculoskeletal disorders. OBJECTIVE: To compare the effectiveness of intra-articular dextrose injecti...
Risk factors associated with congenital hypothyroidism: a case-control study in southeast Iran
BACKGROUND AND AIM: Congenital hypothyroidism (CH) is known as one of the most common preventable cause of mental retardation. This study aimed to determine factors associated with CH in Iran. METHODS: This case-control...
Epidemiological study of snakebites in Ardabil Province (Iran)
INTRODUCTION: Average annual incidence of snakebite worldwide is between 5.5 to 1.2 million, and at least 125,000 of them are fatal. In Iran, around 4,500-11,000 snakebites occur annually, and a small number of them are...
NF-E2-related factor 2 over-expression in mesenchymal stem cells to improve cellular cardiomyoplasty
Myocardial infarction (MI) is the leading cause of death worldwide. Various therapeutic strategies have been introduced for MI treatment. In recent years, interest in utilizing mesenchymal stem cells (MSCs) for MI therap...